Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features
- PMID: 39861908
- PMCID: PMC11768941
- DOI: 10.3390/v17010119
Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features
Abstract
Pityriasis rosea (PR) is a self-limited exanthem associated with the endogenous systemic reactivation of human herpesvirus (HHV)-6 and HHV-7. The disease typically begins with a single erythematous patch on the trunk (herald patch), followed by a secondary eruption of smaller papulosquamous lesions. Rarely, the herald patch may be the only cutaneous manifestation of PR. The present work aimed to examine the clinical and laboratory features of the PR cases characterized by the herald patch as the sole cutaneous manifestation and to compare them with the classic form of PR. An observational, retrospective study was conducted on patients presenting with herald patch as the only sign of PR (cases) and on a series of age- and sex-matched patients who presented with a typical PR pattern (controls). The records of the patients were extracted from a PR registry, which collected data on patients with PR diagnosed from 2003 to 2023 by at least two dermatologists from the same study team. Nineteen patients (eleven males, eight females) with a mean age of 27.1 years presented the herald patch as the only cutaneous manifestation of PR. Nineteen age- and sex-matched patients were considered controls. In the cases, the exanthem duration was shorter than in controls, and the mean HHV-6 and HHV-7 DNA plasma load was lower than in controls. This rare variant of PR might be considered an abortive form of the exanthem that occurs when the HHV-6/7 reactivation from latency is contrasted by a more robust immunological response than in classic PR.
Keywords: atypical exanthems; cutaneous lesions; cytokine profile; differential diagnosis; herald patch; human herpesvirus-6 (HHV-6); human herpesvirus-7 (HHV-7); immunological response; pityriasis rosea; viral reactivation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.Dermatology. 2015;231(1):9-14. doi: 10.1159/000381285. Epub 2015 May 12. Dermatology. 2015. PMID: 25997658
-
Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.Dermatology. 2015;230(1):23-6. doi: 10.1159/000368352. Epub 2015 Jan 16. Dermatology. 2015. PMID: 25612842
-
Pityriasis Rosea: An Updated Review.Curr Pediatr Rev. 2021;17(3):201-211. doi: 10.2174/1573396316666200923161330. Curr Pediatr Rev. 2021. PMID: 32964824 Review.
-
Oropharyngeal lesions in pityriasis rosea.J Am Acad Dermatol. 2017 Nov;77(5):833-837.e4. doi: 10.1016/j.jaad.2017.06.033. Epub 2017 Jul 18. J Am Acad Dermatol. 2017. PMID: 28728872
-
Pityriasis Rosea: A Comprehensive Classification.Dermatology. 2016;232(4):431-7. doi: 10.1159/000445375. Epub 2016 Apr 21. Dermatology. 2016. PMID: 27096928 Review.
References
-
- Chuh A., Zawar V., Sciallis G.F., Kempf W., Lee A. Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? Infect. Dis. Rep. 2016;8:6418. doi: 10.4081/idr.2016.6418. - DOI - PMC - PubMed
-
- Broccolo F., Drago F., Careddu A.M., Foglieni C., Turbino L., Cocuzza C.E., Gelmetti C., Lusso P., Rebora A.E., Malnati M.S. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J. Invest. Dermatol. 2005;124:1234–1240. doi: 10.1111/j.0022-202X.2005.23719.x. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials